Morphea - Morfeya
☆ Germaniyaning 2022 yilgi Stiftung Warentest natijalariga ko'ra, iste'molchilarning ModelDermdan qoniqish darajasi pullik teletibbiyot maslahatlariga qaraganda bir oz pastroq bo'lgan.
Morfeya (Morphea) ning shikastlanishi odatda atrofik pigmentli yamoq shaklida namoyon bo'ladi.
References
Scleroderma - biriktiruvchi to'qimalarga ta'sir qiladigan, qotib qolgan teri shaklida namoyon bo'ladigan va ba'zan tananing boshqa qismlariga ta'sir qiladigan kam uchraydigan kasallik. Ikkita asosiy tur mavjud: teri va ichki organlarning qattiqlashishini o'z ichiga olgan systemic sclerosis va morfeya deb ham ataladigan localized scleroderma , odatda teri va uning ostidagi to'qimalar bilan cheklangan, yaxshi va o'z-o'zini cheklovchi kurs bilan. Mahalliylashtirilgan skleroderma kamdan-kam uchraydi va uning sababi aniq bo'lmasa-da, so'nggi tadqiqotlar shuni ko'rsatadiki, u ichki organlarga ham ta'sir qilishi va turli xil sog'liq muammolariga olib kelishi mumkin. Localized scleroderma potentsial jiddiyligini hisobga olgan holda, asoratlarni oldini olish uchun erta davolash juda muhimdir.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , shuningdek, mahalliylashtirilgan skleroderma sifatida ham tanilgan, biriktiruvchi to'qimalarga ta'sir qiluvchi noyob otoimmün kasallikdir. U turli yo'llar bilan namoyon bo'lishi mumkin va bu juda keng tarqalgan emas, har yili 100 000 kishiga taxminan 0. 4 - 2. 7 holat. Morphea ko'pincha 2 yoshdan 14 yoshgacha bo'lgan bolalarda uchraydi va u o'g'il bolalarga qaraganda qizlarga ko'proq ta'sir qiladi.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morfeya juda kam uchraydigan kasallikdir. Fotosurat tarkibiga ko‘ra, algoritm uni morfeya (morphea) deb xato qilgan bo‘lishi mumkin.